0001671858-17-000002.txt : 20170206 0001671858-17-000002.hdr.sgml : 20170206 20170206151129 ACCESSION NUMBER: 0001671858-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170206 DATE AS OF CHANGE: 20170206 EFFECTIVENESS DATE: 20170206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silverback Therapeutics, Inc. CENTRAL INDEX KEY: 0001671858 IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-261100 FILM NUMBER: 17575375 BUSINESS ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-456-2900 MAIL ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 D/A 1 primary_doc.xml X0707 D/A LIVE 0001671858 Silverback Therapeutics, Inc. 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 206-456-2900 DELAWARE None None Corporation true 2016 Peter A. Thompson 500 Fairview Ave., North, Ste. 600 Seattle WA WASHINGTON 98109 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001671858-16-000002 2016-04-01 true true false 0 60000000 10000001 49999999 false 1 0 0 0 false Silverback Therapeutics, Inc. Jill E. Fishbein Jill E. Fishbein Secretary 2017-02-06